1. The Global Crisis: Why Antibiotics Alone Are No Longer Sufficient

Since Alexander Fleming discovered penicillin, antibiotics have saved millions of lives. However, we are now in the era of antibiotic resistance. Bacteria such as MRSA (methicillin-resistant Staphylococcus aureus) or the feared carbapenem-resistant Enterobacteriaceae (CRE) have developed mechanisms to simply ignore chemical attacks.

The WHO warns: without new antibiotic resistance solutions, we could fall back into a “pre-antibiotic era” in which routine operations or simple scratches could prove fatal. Furthermore, the development of new antibiotics has stalled for years, as it is expensive, time-consuming, and often economically unattractive for the pharmaceutical industry. This is where bacteriophage therapy comes in—not only as a replacement, but as an intelligent partner.

2. What Are Bacteriophages? An Excursion into Microbiology

Bacteriophages, or phages for short, are the most abundant biological entities on Earth. They are viruses that exclusively infect bacteria. They have no metabolism of their own and are completely harmless to humans, animals, and plants.

A Historical Perspective

Long before the widespread availability of penicillin, phages were successfully used to combat infections as early as the 1920s—primarily by pioneers such as Félix d’Hérelle. While the West focused on antibiotics, knowledge of phages remained alive in Eastern Europe, particularly in Georgia (Eliava Institute in Tbilisi). Today, this knowledge is returning to global awareness as part of personalized medicine.

3. The Synergy Study: When 1 + 1 Equals More Than 2

The current study by Gu Liu et al. (2020) provides crucial evidence for the effectiveness of combination therapy. The central concept is phage-antibiotic synergy (PAS).

What Does PAS Mean in Detail?

In microbiology, synergy describes a state in which two substances together produce a significantly higher bacterial mortality rate than would be expected from simply adding their individual effects. The study examined how phages influence the minimum inhibitory concentration (MIC) of antibiotics.

The Key Findings of the Research:

• Efficacy Boost: Under the influence of phages, resistant bacteria became susceptible again to agents such as beta-lactams.

• Prevention of “Persisters”: Antibiotics alone often leave behind dormant bacterial cells (persisters) that later trigger new infections. Phages can occupy these niches and increase the eradication rate.

• Dependence on Drug Class: The study emphasizes that not every antibiotic harmonizes with every phage. While beta-lactams often delivered excellent results, quinolones such as ciprofloxacin showed partially antagonistic (inhibitory) effects.

Find the complete study by Gu Liu et al. (2020) here

4. Mechanisms of Synergy: How Do They Attack Together?

Why is the combination so effective? It is a coordinated attack on two levels:

The Evolutionary Dilemma

Bacteria face a dilemma. If they develop resistance to the phage (e.g., by altering their surface receptors), they often simultaneously lose their resistance to the antibiotic. If they protect themselves against the antibiotic (e.g., through efflux pumps), they often become more susceptible to phage attack. This process is called resistance costs (fitness costs).

Cell Wall Stress

Antibiotics such as penicillin weaken the bacterial cell wall. A weakened bacterium is less able to withstand the internal pressure that builds when phages replicate millions of times inside the cell. The bacterium bursts (lysis) more quickly and releases new phages that infect the next host cells.

5. Phages in Practice: From the Clinic to Skincare

Bacteriophage therapy is not limited to the intensive care unit. There are two major fields of application:

A. Clinical Application in Chronic Infections

Phages are particularly superior in stubborn biofilms—mucous layers in which bacteria hide from antibiotics. They produce enzymes (depolymerases) that literally “digest” the biofilm, clearing the way for antibiotics. This is crucial in:

• Chronic bone infections (osteitis).

• Infected wounds in diabetes (diabetic foot).

• Cystic fibrosis patients with Pseudomonas infections.

B. Dermatological Innovations

Phages are also gaining importance in skincare. Since they do not destroy the natural skin microbiome, they offer a gentle solution for acne or rosacea. Unlike aggressive creams, they eliminate only the causes of inflammation.

6. Challenges and the Path to Standard Therapy

Despite the enthusiasm, there are obstacles. The study by Gu Liu makes clear that the environment matters. In laboratory tests (in vitro), the synergies are often massive. In the human body (in vivo), however, phages interact with:

• The Immune System: Blood plasma can neutralize phages before they reach the bacteria.

• Body Fluids: Urine or gastric acid can affect the stability of the viruses.

Furthermore, regulatory approval is complex. Since phages are “living medicines,” they do not fit into the conventional approval framework for static chemicals.

7. Looking East: What We Can Learn from Georgia

While clinical trials are still ongoing in Western Europe, phage cocktails have been sold in pharmacies in Georgia for nearly 100 years. The comparison shows: successful therapy often requires a mixture of different phages to cover a broad spectrum and immediately nip resistance in the bud. Integrating this wealth of experience into Western evidence-based medicine is one of the most important tasks of the coming years.

---

FAQ – Frequently Asked Questions

1. Can bacteria also become resistant to phages? Yes, that is possible. However, unlike antibiotics, phages evolve along with bacteria. In therapy, “phage cocktails” are usually used, so the bacterium would have to become resistant to multiple phages simultaneously, which is extremely unlikely.

2. Why are phages not simply used instead of antibiotics? Phages and antibiotics have different strengths. Antibiotics work quickly and broadly, phages work specifically and sustainably. The study shows that the combination often represents the safest way to eliminate all bacteria.

3. Does phage therapy have side effects? Since phages only attack bacteria, they are non-toxic to human cells. Occasionally, the massive destruction of bacteria can lead to the release of endotoxins, which may briefly cause fever—a reaction to the dying bacteria, not to the phages themselves.

4. Where can I receive phage therapy? In Germany, the therapy is usually only possible as an individual compassionate use treatment when all other options have failed. Centers in Belgium or Georgia are more advanced in this regard.

5. Can I simply stop taking antibiotics if I use phages? This should only be done in consultation with specialized physicians. As the study by Gu Liu shows, both agents often reinforce each other. Discontinuing the antibiotic could negate the synergistic advantage.

---

Conclusion: The Future Is Combined

Phage-antibiotic synergy is far more than a scientific experiment. It is a necessary evolution of our infection strategy. By combining the precision of nature (phages) with the raw power of chemistry (antibiotics), we create an alliance that even the most dangerous superbugs can barely counter.

For patients, this means: hope for healing, even when all conventional therapies have failed. For medicine, it means: a more sustainable approach to our precious antibiotics.

---

Sources & Further Links:

• Liu, G. et al. (2020). Study on Phage-Antibiotic Synergy.

• WHO report on antibiotic resistance.

• Internal resources at www.Phage.help on areas of application.